Loading...

SOHO 2026 Annual Meeting

This website and third-party tools we use rely on cookies for the best user experience. By selecting "I agree", you agree to cookie usage as described in our Privacy Policy.

1,267 posters, 47 videos, 13 topics, 4 sessions, 853 authors

ePostersLive by SciGen Technologies S.A. All rights reserved.

SOHO 2026 Annual Meeting

September 9 - 12, 2026 | George R. Brown Convention Center, Houston, Texas

Home Posters by Code Posters by Title Authors Affiliations Topics Sessions Videos Audios Previous meetings

Posters by Title

Type your Poster Title, then hit apply

Showing 1,267 results.

Thumbnail for Treatment of high-risk smoldering multiple myeloma (HRSMM) with Isatuximab, lenalidomide, oral Cyclophosphamide and Dexamethasone: a survival advantage

MM - 633

Treatment of high-risk smoldering multiple myeloma (HRSMM) with Isatuximab, lenalidomide, oral Cyclophosphamide and Dexamethasone: a survival advantage

Maher Salamoon

Poster Presenter: Maher Salamoon

Thumbnail for Treatment of higher risk Myelodysplastic Syndrome HR-MDS with high-dose chemotherapy followed by lenalidomide and azacitidine: a four-year survival update

MDS - 635

Treatment of higher risk Myelodysplastic Syndrome HR-MDS with high-dose chemotherapy followed by lenalidomide and azacitidine: a four-year survival update

Maher Salamoon

Poster Presenter: Maher Salamoon

Previous 1...128 129 130 131 132 133 134...141 Next

Copyright © 2015-2026, ePostersLive® SciGen is a registered trademark of SciGen Technologies S.A. Patent pending.

Thumbnail for Treatment of peripheral T-cell lymphoma with dose-dense, dose-intense chemotherapy as well as Avelumab and Brentuximab Vedutin

TCL - 1227

Treatment of peripheral T-cell lymphoma with dose-dense, dose-intense chemotherapy as well as Avelumab and Brentuximab Vedutin

Maher Salamoon

Poster Presenter: Maher Salamoon

Thumbnail for Treatment Outcomes and Prognostic Factors in Elderly Patients with Newly Diagnosed Peripheral T-Cell Lymphoma

TCL - 1326

Treatment Outcomes and Prognostic Factors in Elderly Patients with Newly Diagnosed Peripheral T-Cell Lymphoma

Omar Elghawy

Poster Presenter: Omar Elghawy

Thumbnail for Treatment Outcomes and Relapse Dynamics in Burkitt Lymphoma: Real-World Data From a National Latin American Reference Center

ABCL - 232

Treatment Outcomes and Relapse Dynamics in Burkitt Lymphoma: Real-World Data From a National Latin American Reference Center

Andy Yajaira Mejia-Castro

Poster Presenter: Andy Yajaira Mejia-Castro

$Thumbnail for Treatment Patterns and Clinical Outcomes Among Patients With Treatment-Naοve and Relapsed/Refractory (R/R) Mantle Cell Lymphoma (MCL) in Community Practice Between 2020 and 2025$

MCL - 1296

Treatment Patterns and Clinical Outcomes Among Patients With Treatment-Naοve and Relapsed/Refractory (R/R) Mantle Cell Lymphoma (MCL) in Community Practice Between 2020 and 2025

Javier Munoz

Poster Presenter: Javier Munoz

Thumbnail for Treatment Patterns and Outcomes of Ivosidenib in Patients With mIDH1 AML Previously Treated With Venetoclax-Based Regimens: A Real-World Analysis

AML - 776

Treatment Patterns and Outcomes of Ivosidenib in Patients With mIDH1 AML Previously Treated With Venetoclax-Based Regimens: A Real-World Analysis

Vanessa Kennedy

Poster Presenter: Vanessa Kennedy

Thumbnail for Treatment Patterns and Outcomes with Olutasidenib After Venetoclax in IDH1-Mutated AML Using Real-World Data from Chart Review

AML - 792

Treatment Patterns and Outcomes with Olutasidenib After Venetoclax in IDH1-Mutated AML Using Real-World Data from Chart Review

Amber Thomasson

Poster Presenter: Amber Thomasson

$Thumbnail for Treatment Preferences and Perceived Barriers to Epcoritamab Plus Rituximab and Lenalidomide in Relapsed/Refractory Follicular Lymphoma: A Real-World Survey of US Hematologists/Oncologists$

IBCL - 236

Treatment Preferences and Perceived Barriers to Epcoritamab Plus Rituximab and Lenalidomide in Relapsed/Refractory Follicular Lymphoma: A Real-World Survey of US Hematologists/Oncologists

Blaise Nwotchouang

Poster Presenter: Blaise Nwotchouang

ePosters in

Topics Sessions

Acute Lymphoblastic Leukemia (ALL)(71)Acute Myeloid Leukemia (AML)(230)Aggressive B-Cell Lymphoma (ABCL)(114)Cellular Therapy (CT)(128)Chronic Lymphocytic Leukemia (CLL)(110)Chronic Myeloid Leukemia (CML)(55)Hodgkin Lymphoma (HL)(54)Indolent B-Cell Lymphoma (IBCL)(47)Mantle Cell Lymphoma (MCL)(23)Multiple Myeloma (MM)(234)

Previous 1 2 Next

Sponsors